Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
Clinical trial NCT00079937 · COMPLETED
Trial details
- NCT number
- NCT00079937
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2008-03-01
- Enrollment
- 628
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.